Skip to content
10-Q

Quarterly Report

NEKTAR THERAPEUTICS NKTR

0000950170-25-105275

← back to feed
Filed
Aug 8, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Jul 31, 2025 19.02M sh
Shares Diluted Q2 2025 · Jun 30, 2025 14.09M sh
Shares Diluted Q2 2025 · Jun 30, 2025 14.07M sh
Shares Diluted restated Q2 2025 · Jun 30, 2024 13.92M sh
Shares Diluted restated Q2 2025 · Jun 30, 2024 13.45M sh
Stock Repurchased Q2 2025 · Jun 30, 2025 $0
Stock Repurchased Q2 2025 · Jun 30, 2024 $3M
Capex Q2 2025 · Jun 30, 2025 $39K
Capex Q2 2025 · Jun 30, 2024 $343K
Operating Cash Flow Q2 2025 · Jun 30, 2025 −$94.79M
Operating Cash Flow Q2 2025 · Jun 30, 2024 −$85.59M
Cash And Equivalents Q2 2025 · Jun 30, 2025 $42.99M
Cash And Equivalents Q2 2025 · Dec 31, 2024 $44.25M
Stockholders Equity Q2 2025 · Jun 30, 2025 −$24.21M
Stockholders Equity Q2 2025 · Mar 31, 2025 $13.74M
Stockholders Equity Q2 2025 · Dec 31, 2024 $60.74M
Stockholders Equity Q2 2025 · Jun 30, 2024 $79.69M
Stockholders Equity Q2 2025 · Mar 31, 2024 $126.71M
Stockholders Equity Q2 2025 · Dec 31, 2023 $130.99M
Current Liabilities Q2 2025 · Jun 30, 2025 $71.39M
Current Liabilities Q2 2025 · Dec 31, 2024 $61.4M
Total Liabilities Q2 2025 · Jun 30, 2025 $231.75M
Total Liabilities Q2 2025 · Dec 31, 2024 $243.11M
Current Assets Q2 2025 · Jun 30, 2025 $186.57M
Current Assets Q2 2025 · Dec 31, 2024 $261.29M
Total Assets Q2 2025 · Jun 30, 2025 $207.53M
Total Assets Q2 2025 · Dec 31, 2024 $303.85M
Eps Diluted Q2 2025 · Jun 30, 2025 −$2.95
Eps Diluted Q2 2025 · Jun 30, 2025 −$6.57
Eps Diluted restated Q2 2025 · Jun 30, 2024 −$3.76
Eps Diluted restated Q2 2025 · Jun 30, 2024 −$6.63
Eps Basic Q2 2025 · Jun 30, 2025 −$2.95
Eps Basic Q2 2025 · Jun 30, 2025 −$6.57
Eps Basic restated Q2 2025 · Jun 30, 2024 −$3.76
Eps Basic restated Q2 2025 · Jun 30, 2024 −$6.63
Sga Expense Q2 2025 · Jun 30, 2025 $17.07M
Sga Expense Q2 2025 · Jun 30, 2025 $41.42M
Sga Expense Q2 2025 · Jun 30, 2024 $20.51M
Sga Expense Q2 2025 · Jun 30, 2024 $40.66M
Rd Expense Q2 2025 · Jun 30, 2025 $29.89M
Rd Expense Q2 2025 · Jun 30, 2025 $60.37M
Rd Expense Q2 2025 · Jun 30, 2024 $29.72M
Rd Expense Q2 2025 · Jun 30, 2024 $57.13M
Net Income Q2 2025 · Jun 30, 2025 −$41.59M
Net Income Q2 2025 · Jun 30, 2025 −$92.48M
Net Income Q2 2025 · Jun 30, 2024 −$52.36M
Net Income Q2 2025 · Jun 30, 2024 −$89.17M
Operating Income Q2 2025 · Jun 30, 2025 −$36.23M
Operating Income Q2 2025 · Jun 30, 2025 −$80.77M
Operating Income Q2 2025 · Jun 30, 2024 −$49.77M
Operating Income Q2 2025 · Jun 30, 2024 −$85.2M
Cost Of Revenue Q2 2025 · Jun 30, 2025 $0
Cost Of Revenue Q2 2025 · Jun 30, 2025 $0
Cost Of Revenue Q2 2025 · Jun 30, 2024 $9.74M
Cost Of Revenue Q2 2025 · Jun 30, 2024 $18.27M
Revenue Q2 2025 · Jun 30, 2025 $11.18M
Revenue Q2 2025 · Jun 30, 2025 $21.64M
Revenue Q2 2025 · Jun 30, 2024 $23.49M
Revenue Q2 2025 · Jun 30, 2024 $45.13M